Delivery Order SPE2DB22D3501-SPE2DB24FTJ11
Award Date
10/27/23
Potential Completion Date
10/30/23
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,259.73, is for the delivery of oxcarbazepine 300 mg/5 ml suspension, a generic anticonvulsant medication, with a completion date of February 25, 2025. The contract is a firm-fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $2,874.78 and a period of performance through April 1, 2025. The contract is a Firm Fixed Price Delivery Order, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of 4,562,004,306 milliliters of Oxcarbazepine 300 mg/5 mL suspension in 250 mL bottles. The Firm Fixed Price delivery order, valued at $3,385.08, has an ultimate completion date of August 31, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,025.75, is for the delivery of 4564543492 - Oxcarbazepine 300 mg/5 ml suspension, 250 ml. The contract has an ultimate completion date of May 9, 2024 and is a Firm Fixed Price Delivery Order. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,561,502,477 units of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The contract has a ceiling value of $1,544.40 and is a Firm Fixed Price Delivery Order, with a completion date of July 17, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a...
This federal contract award is for the delivery of Oxcarbazepine 300 mg/5 ml Suspension, 250 ml to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,161.36, was awarded to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of July 26, 2024. It is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles. The $4,104.42 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,694.28, is for the delivery of OXCARBAZEPINE 300 MG/5 ML SUSP 250ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order, valued at $3,890.30, is for the supply of 4,558,996,119 Oxcarbazepine 300 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the...
This is a delivery order under a Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of Oxcarbazepine 300 mg/5 ml suspension in 250 ml bottles, with a ceiling value of $11,218.95 and a completion date of June 18, 2024. This order is not designated as a set-aside contract. AmerisourceBergen holds a large IDC with the DLA Troop...